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A biologic activity isolated from toxic
Pfiesteria piscicida cultures has been deter-
mined to activitate c-fos luciferase in GH4C1
cells (1). P. piscicida is a heterotrophic estuar-
ine dinoflagellate discovered in 1991 by
Burkholder and co-workers (2); it has been
implicated as the causative agent of major ﬁsh
kills and ﬁsh disease in the two largest U.S.
mainland estuaries (the Albemarle-Pamlico of
North Carolina and Chesapeake Bay in
Maryland and Virginia ) (3). P. piscicida was
ﬁrst implicated as hazardous to human health
following accidental exposure of laboratory
workers (4). During 1993–1995, environ-
mental exposures were anecdotally reported in
North Carolina estuaries (4,5), and in 1997
the ﬁrst clinical evaluations of people shortly
after environmental exposure to P. piscicida
blooms were completed in Maryland (6).
People who had contact with toxic P. pisci-
cida waters or with potential toxic aerosols
reported symptoms including dermal lesions
and rashes, a burning sensation on contact
with water, fatigue, respiratory irritation, diar-
rhea, severe headaches, and a neurologic syn-
drome characterized by learning disabilities
manifested as short-term memory dysfunc-
tion and other cognitive impairment (4,6). 
GH4C1 cells are a rat pituitary cell line
that has been used to characterize signaling
pathways for a variety of ﬁrst messengers (7).
They have also proven useful for the investi-
gation of algal-derived toxins including
maitotoxin (8,9) and a biologic activity pro-
duced by Pfiesteria piscicida (1). Each also
caused an increase in ionic conductances and
an elevation of cytosolic free calcium (9,10).
Downstream events include activation of c-
fos luciferase and cytotoxicity (1,11,12). In
vitro methods for characterization of algal-
derived toxins have relied largely upon func-
tional assays that include receptor-based
assays and cell-based toxicity assays (13).
Cell based assays can be further modiﬁed by
changing the end point from the mitochon-
drial indicator for toxicity (MTT dye-based
assay) to speciﬁc gene induction (11). These
assays, known as reporter gene assays, use
responsive cell lines that stably express
reporter gene constructs. 
In this study we investigated the signal-
ing pathways that elicit the reporter gene
response in GH4C1 cells using adenosine-5´-
triphosphate (ATP) as a model compound.
We identiﬁed ATP as a novel ﬁrst messenger
for GH4C1 cells that induces c-fos luciferase
and cytotoxicity. Using a reporter gene assay,
we conducted initial characterization of the
ATP receptor through analog specificity
studies using P2X receptor agonists and
antagonists with differing receptor subtype
selectivity. We then used two classes of P2X
antagonists to examine whether putative P.
piscicida toxin (pPfTx) activates a P2X path-
way in these cells.
Materials and Methods
Stock cultures of stably transfected rat pitu-
itary cells (GH4C1) were maintained in
Ham’s F10 medium supplemented with 15%
horse serum, 2.5% fetal bovine serum (FBS),
and 200 µg/mL neomycin antibiotic (G418;
Gibco Life Technologies, Grand Island, NY).
Cultures were incubated at 37°C with 5%
CO2 and 95% air. GH4C1 stable transfec-
tants were obtained by cotransfecting plas-
mids c-fos-luc and pSV2-neo (Richard N.
Day, University of Virginia, Charlottesville,
VA), as previously described (1). We pur-
chased rabbit anti-rat P2X7 receptor antibody
from Alomone Labs, Ltd., (Jerusalem, Israel).
Toxin isolation. We used an actively
growing, ﬁsh-killing culture of P. piscicida for
toxin isolation. Using methods described pre-
viously (14), we isolated the cultures from a
ﬁsh kill and toxic P. piscicida outbreak in the
Neuse Estuary in North Carolina using ﬁsh
bioassays and water samples taken from the
in-progress kill. P. piscicida from the fish-
killing bioassays was cloned and grown with
algal prey under axenic conditions (but with
bacterial endosymbionts retained in the P.
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We examined the pharmacologic activity of a putative toxin (pPfTx) produced by Pﬁesteria pisci-
cida by characterizing the signaling pathways that induce the c-fos luciferase construct in GH4C1
rat pituitary cells. Adenosine-5´-triphosphate (ATP) was determined to increase and, at higher
concentrations, decrease luciferase activity in GH4C1 rat pituitary cells that stably express c-fos
luciferase. The inhibition of luciferase results from cytotoxicity, characteristic of the putative P.
piscicida toxin (pPfTx). The actions of both pPfTx and ATP to induce c-fos luciferase were inhib-
ited by the purinogenic receptor antagonist pyridoxalphosphate-6-azophenyl-2´,4´-disulfonic acid
(PPADS). Further characterization of a P2X receptor on the GH4C1 cell was determined by the
analog selectivity of P2X agonists. The P2X1/P2X3 agonist α ,β -methylene ATP (α ,β -MeATP)
failed to increase or decrease c-fos luciferase. However, the P2X7 agonist 2´,3´-(4-benzoyl)benzoyl
ATP (BzATP), which had a predominant cytotoxic effect, was more potent than ATP.
Immunoblot analysis of GH4C1 cell membranes conﬁrmed the presence of a 70-kDa protein that
was immunoreactive to an antibody directed against the carboxy-terminal domain unique to the
P2X7 receptor. The P2X7 irreversible antagonist oxidized-ATP (oxATP) inhibited the action of
ATP, BzATP, and pPfTx. These ﬁndings indicate that GH4C1 cells express purinogenic receptors
with selectivity consistent with the P2X7 subtype and that this receptor pathway mediates the
induction of the c-fos luciferase reporter gene by ATP and the putative Pﬁesteria toxin. Key words:
c-fos, GH4C1, P2X7, Pfiesteria, pituitary, purinergic, toxin. Environ Health Perspect
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postulates modified for toxic rather than
infectious agents, the axenic clonal P. piscicida
culture (with bacterial endosymbionts) and
residual benign algal prey (< 5 cryptomon-
ads/mL) were added to cultures of healthy
ﬁsh (n = 4). Control ﬁsh cultures were treated
identically, except that they received similar
addition of only residual cryptomonad culture
without P. piscicida (n = 4, with each replicate
containing three tilapia (Oreochromis mossam-
bica). Fish death occurred and was repeated as
additional live ﬁsh were added to the cultures
of P. piscicida. In contrast, control ﬁsh, which
had been maintained identically but with
addition of benign algal prey and not P. pisci-
cida, remained healthy (14). 
We identified P. piscicida to species at
three levels of isolation: from the ﬁsh bioassays
of water collected from the Neuse fish kill,
from the clonal isolate grown with algal prey,
and from the subsequent mass-culture with
fish. Species identification was completed
from analysis of suture-swollen zoospore cells
by scanning electron microscopy (15).
Following standard procedure in the
Burkholder/Glasgow laboratory, the species
identiﬁcations were then cross-conﬁrmed by
three independent laboratories. Molecular
probe analyses was conducted by D. Oldach
[heteroduplex mobility assay to verify both the
species identification and uni-dinoflagellate
culture status (16)] and P. Rublee [ﬂuorescent
in situ hybridization rDNA probe for P. pisci-
cida (17)]. Scanning electron microscopy was
conducted by K. Steidinger and co-workers
(Florida Fish and Wildlife Conservation
Commission Florida Marine Research
Institute, St. Petersburg, FL) and by H.
Marshall and D. Seaborn (Old Dominion
University, Norfolk, VA). 
We mass-cultured the toxic P. piscicida
isolate with live tilapia in a biohazard III
facility (14,15). They were maintained in 15-
psu (practical salinity unit) sterile-ﬁltered sea-
water (water source 8 km off Beaufort, NC,
diluted using deionized water), or in 15-psu
water made using Instant Ocean salts
(Aquarium Systems, Mentor, OH) and
deionized water. Toxic samples were taken
from cultures that were actively killing tilapia
at the time of collection. The toxic seawater
medium was passed through a preparative
C18 column and ﬂushed with fresh water to
remove the excess salts. The toxic material
was then eluted from the column with 100%
methanol. This methanol elutant was con-
centrated and passed through a silica gel col-
umn using an elutropic scheme of increasing
polarity. We screened fractions for cytotoxic-
ity and reporter gene activity using GH4C1
cells as previously described (1). The greatest
P. piscicida activity was found to elute in the
later, more polar fractions. These fractions
were evaporated to dryness and then were
placed under high vacuum to remove any
remaining organic solvents that would inter-
fere with the bioassays. The dry residue was
taken up in standard volumes of methanol as
the carrier solvent for further analysis. The
active fraction was determined not to contain
ATP by difference in chromatographic reten-
tion and by lack of ATP activity using an
ATP-dependent in vitro luciferase assay,
described below under “ATP Assay.” Because
the chemical structure of the bioactive sub-
stance has not yet been determined in the
absence of a sufﬁcient quantity of toxic cul-
ture to enable puriﬁcation, the bioactive sub-
stance is referred to here as putative P.
piscicida toxin (pPfTx).
Reporter gene assay. GH4C1 c-fos-luc
cells were seeded in a 96-well clear-bottom
white plate (Corning Costar, Cambridge,
MA) at a density of 30,000 cells/well in 100
mL culture media and allowed to incubate
overnight to ensure cell attachment. Cells
treated with pPfTx were incubated for 4 hr
and those with ATP were incubated for 10
hr. All incubations were performed at 37°C
with 5% CO2 and 95% air. In experiments
where oxidized-ATP (oxATP) was used, pre-
treatment of one group of wells with 400
mM oxATP was initiated 1 hr before cell
treatment with increasing concentrations of
either ATP, 2´,3´-(4-benzoyl)benzoyl ATP
(BzATP) or pPfTx. After incubation, the
experimental media was removed and 20 mL
cell lysis buffer [1% Triton X-100, 5 mM
Tris, 0.4 mM trans-1,2-diaminocyclohexane-
N,N,N´,N´-tetraacetic acid (CDTA), 10%
glycerol, pH 7.8, and 1 mM dithiothreitol
(DTT)] was added to each well. Lysis was
allowed to proceed at room temperature for
20 min; we then measured solubilized
luciferase protein activity using a luminome-
ter (LumiStar; BMG LabTechnologies,
Durham, NC). The luminometer was pro-
grammed to inject each well with 20 µL of
Luciferase Assay Reagent (Promega,
Madison, WI), and read the luminescence
generated for 10 sec. 
Immunostaining. We performed immuno-
staining for P2X7 receptors using cell
homogenates of GH4C1 cells on Western
transfers. GH4C1 cells were removed from
100-mm dishes with PBS-EDTA and resus-
pended in PBS containing protease
inhibitors (4 µM phenylmethylsulfonyl ﬂuo-
ride and 2 µg/mL each of pepstatin, leu-
peptin, trypsin inihibitor, and aprotinin).
Cells were lysed by freeze-thawing and then
sonicated at 50 W, three pulses of 20 sec on
ice. The lysates were centrifuged at 10,000 ×
g for 20 min, and supernatants were sepa-
rated by 7.5% SDS-polyacrylamide gel elec-
trophoresis. Separated proteins were then
transferred to nitrocellulose and incubated
with 1:200 rabbit anti-rat P2X7 antibody
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Figure 1. Induction of c-fos luciferase in GH4C1
cells treated with increasing concentrations of
ATP. RLU, relative light units. See “Materials and
Methods” for details. Each point represents the
mean ± SE of three wells for an experiment
repeated three times with similar results. 
Figure 2. Induction of c-fos luciferase in GH4C1 cells treated with increasing concentrations of pPfTx. See
“Materials and Methods” for details. RLU, relative light units. Each point represents the mean ± SE of three
wells for an experiment repeated twice with similar results.
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Triton-X100 between antibody incubations.
The detection was electrogenerated chemilu-
minscence according to the manufacturer
(Amersham, Buckinghamshire, UK) for 5
min. The transfers were then exposed to
Hyperﬁlm-ECL (Sigma, St. Louis, MO) for
60 sec and developed with an X-ray proces-
sor. The corresponding blocking peptide
(P2X7 576–595 peptide) at 10 µg/mL was
incubated with the same antibody solution
for 1 hr at 23°C. Transfers were then probed
and developed as described above.
ATP assay. We used the ATP Biolumi-
nescent Assay Kit (Sigma, St. Louis, MO) to
determine the amount of ATP present in
pPfTx samples. The assay kit contained ATP
Standard (2.0 µmol ATP), ATP Assay Mix
Dilution Buffer (MgSO4, DTT, EDTA,
bovine serum albumin, tricine buffer salts),
and ATP Assay Mix (luciferase, luciferin,
MgSO4, DTT, EDTA, bovine serum albu-
min, tricine buffer salts). We made serial
dilutions from the ATP Standard after it had
been diluted to a concentration of 40 µM in
double-distilled H2O. We plated 40 µL of
each serial dilution in triplicate in a 96-well
plate. pPfTx was plated in triplicate alongside
the ATP Standard. We added 40 µL ATP
Assay Mix diluted 1:25 with ATP Assay
Dilution Buffer to each well; the lumines-
cence was generated by the catalyzing activity
and measured by a luminometer.
Results
Effect of ATP and pPfTx on c-fos luciferase.
We examined ATP for its ability to mimic
the action of pPfTx in GH4C1 cells. A
biphasic luciferase response was generated
from the induction of the GH4C1 cells with
increasing concentrations of ATP (Figure 1).
We observed a half-maximal effect at 30
mM, with a maximal effect occurring at 200
mM. Concentrations of ATP that exceeded
200 mM caused a concentration-dependent
inhibition of c-fos luciferase. This decrease is
associated with cytotoxicity as determined by
MTT cytotoxicity assay. A similar biphasic
c-fos luciferase response was generated by the
addition of serial dilutions of pPfTx to
GH4C1 cells (Figure 2). These results indi-
cate that pPfTx mimics the action of ATP to
induce c-fos luciferase and cytoxtoxicity in
GH4C1 cells and lead us to conduct prelimi-
nary characterization of the ATP receptor on
GH4C1 cells.
Analog characterization of the ATP
receptor in GH4C1 cells. The preliminary
characterization of the ATP receptor was
determined by conducting analog selectivity
studies. The primary analogs tested that were
effective in this study are shown in Figure 3.
We first tested the moderately selective P2
antagonist, pyridoxalphosphate-6-azophenyl-
2´,4´-disulfonic acid (PPADS). PPADS
caused concentration-dependent inhibition
of c-fos luciferase in the presence and absence
of added ATP (Figure 4). The inhibition of
c-fos luciferase by PPADS was not associated
with cytotoxicity. We next examined the
P2X1 and P2X3 subtype selective agonist
α ,β -methyleneadenosine 5´-triphosphate
(α ,β -MeATP). α ,β -MeATP failed to increase
or decrease c-fos luciferase activity (Figure 5).
Taken together, these results indicate that if
P2X receptors mediate the effects of ATP on
c-fos luciferase in GH4C1 cells, the receptor is
not of the P2X1 or P2X3 subtype. 
We next examined a second antagonist,
oxATP, which is an irreversible P2X antago-
nist with moderate selectivity for P2X7 recep-
tors. Pretreatment with 400 µM oxATP
inhibited the majority of the effect of ATP to
increase c-fos luciferase, and fully inhibited the
effects of ATP to decrease luciferase (Figure
6). oxATP, unlike PPADS, did not decrease
c-fos luciferase activity. We next tested the
action of an agonist, BzATP, that shows selec-
tivity for P2X7 receptors. BzATP did not
increase c-fos luciferase activity, but it caused
concentration-dependent inhibition of c-fos
luciferase activity (Figure 7). The half-maxi-
mal effect of BzATP was nearly 10 times
lower than the half-maximal effect of ATP to
inhibit c-fos luciferase. This is consistent with
an action on P2X7 subtype purinoreceptors.
The failure of BzATP to induce c-fos
luciferase was unexpected. It is possible that
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Figure 3. Structures for ATP and selected analogs. 
Figure 4. PPADS inhibition of ATP induction of
c-fos luciferase in GH4C1 cells of PPADS. RLU, rel-
ative light units. See “Materials and Methods” for
details. Each point represents the mean ± SE of
three wells for an experiment repeated once with
similar results. 
Figure 5. Effect of ATP and α ,β -MeATP on c-fos
luciferase in GH4C1 cells. RLU, relative light units.
See “Materials and Methods” for details. Each
point represents the mean ± SE of three wells for
an experiment repeated once with similar results.
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of the biphasic response (i.e., cytotoxicty but
not induction of the reporter gene). An alter-
native possibility is that BzATP induces both
responses but has greater efficacy for
cytotoxicity. We addressed this question by
testing BzATP at the shorter incubation
period of 4 hr and found that BzATP did
cause a biphasic response (data not shown).
We also examined the effect of oxATP on
the action of BzATP. Pretreatment of 400
mM oxATP fully inhibited the effect of
BzATP to decrease luciferase (Figure 7),
which is consistent with an effect mediated
by purinogenic receptors of the P2X7 class. 
Identification of the P2X7 receptor by
immunoblotting. We examined the presence
of the P2X7 receptor by immunostaining
Western transfers of GH4C1 cell membranes.
GH4C1 cells expressed an approximate 70-
kDa band that was immunoreactive to a rab-
bit antibody directed to the intracellular
carboxyl terminal domain, unique to the
P2X7 class of purinergic receptors (Figure 8).
We examined the speciﬁcity of the staining
of the 70-kDa band by preabsorption of the
primary antiserum with 10 µg/mL of the car-
boxyl terminal peptide sequence 575–595.
No immunostaining of the 70-kDa band was
evident under matched conditions (data not
shown). This result provides an additional
line of evidence for the presence of P2X7
receptors on GH4C1 cells.
Testing pPfTx for ATP activity. We
examined the role of P2X7 receptors in the
action of the pPfTx. We sought to determine
whether the pPfTx contained any activity
attributable to ATP. We used an ATP-
dependent luciferase assay to quantify ATP.
The sensitivity of the assay was 40 nM; 4
µM ATP generated a 100-fold increase in
response (Figure 9). pPfTx, given in an
amount that caused a maximal induction of
c-fos luciferase in the reporter gene assay,
failed to mimic any effect of ATP to activate
the luciferase enzyme directly. The pPfTx
contained < 40 nM ATP, but by the reporter
gene assay, it contained 200 µM ATP equiv-
alents, indicating that the effect of pPfTx in
the reporter gene assay is not attributable to
ATP. 
Effect of P2X antagonists on pPfTx
induction of c-fos luciferase. We used two
P2 antagonists of differing selectivity to
examine the role of P2X receptors in the
action of pPfTx to induce c-fos luciferase and
cytotoxicity. PPADS, a P2 agonist, given at
200 µM inhibited both the activity of pPfTx
and ATP (Figure 10). oxATP, an irreversible
P2X antagonist that has selectivity for P2X7
receptors, was added at a concentration of
400 µM as a pretreatment 1 hr before the
addition of increasing concentrations of both
ATP and pPfTx (Figure 11). oxATP inhib-
ited the luciferase induction of both ATP
and pPfTx, suggesting that both substances
induce c-fos luciferase and cytotoxicity by a
common mechanism involving a P2X7 sub-
type receptor.
Discussion
ATP has a dual role as both an energy source
for enzymatic reactions and as a ﬁrst messen-
ger for several classes of G protein-coupled
receptors and ligand-gated ion channels.
ATP was found to induce c-fos luciferase in
GH4C1 cells with a characteristic biphasic
response. pPfTx also induced c-fos luciferase
in a similar manner. These results suggest
that the pPfTx is either ATP or an ATP ago-
nist. We examined whether pPfTx was ATP
using two lines of evidence. The first was
that ATP and pPfTx do not share common
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Figure 6. oxATP inhibition of ATP induction of
c-fos luciferase in GH4C1 cells pretreated with 400
µM oxATP for 1 hr. RLU, relative light units. See
“Materials and Methods” for details. Each point
represents the mean ± SE of three wells for a rep-
resentative experiment repeated once with similar
results. 
Figure 7. BzATP inhibition of c-fos luciferase and
antagonism by oxATP in GH4C1 cells pretreated
either in the absence or presence of 400 µM
oxATP for 1 hr, followed by treatment with
increasing concentrations of BzATP. RLU, relative
light units. See “Materials and Methods” for
details. Each point represents the mean ± SE of 3
wells for a representative experiment, repeated
once with similar results.
Figure 8. Western blot analysis of P2X7 receptor
in GH4C1 cells. See “Materials and Methods” for
details. Preabsorption of the antiserum with the
575–595 peptide of the P2X7 receptor prevented
immunostaining of the 70 kDa band (not shown).
This experiment was repeated three times with
similar results.
Figure 9. Inability of pPfTx to catalyze isolated luciferase enzyme in the presence of cofactors. The catalyz-
ing activity of pPfTx was compared to the ATP standard curve. RLU, relative light units. See “Materials and
Methods” for details. Each point represents the mean ± SE of three wells for an experiment repeated once
with similar results.
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pPfTxchromatographic retention properties (data
not shown). The second was that pPfTx
could not mimic the action of ATP to cat-
alyze isolated luciferase enzyme in the pres-
ence of cofactors. Taken together, these
results indicate that pPfTx is not ATP, but
rather an ATP agonist.
ATP activates receptors of the purino-
genic P2 class (19). P2 receptors are divided
into two classes—P2X and P2Y—based on
molecular structure. P2X receptors are ATP-
activated ion channels, and P2Y receptors are
ATP-activated G protein-coupled receptors.
We began by examining analog selectivity for
induction of c-fos luciferase by ATP using P2
agonists and antagonists of differing selectiv-
ity. PPADS, a P2 antagonist of moderate
selectivity for P2X receptors (19), caused
concentration-dependent inhibition of ATP
induction of c-fos luciferase in GH4C1 cells
with a half-maximal effect (100 µM), which
is consistent with an action on P2 receptors.
Further examination with α ,β -methylene
ATP (α ,β -MeATP), both a P2X1- and
P2X3-selective ATP agonist (19,20), indi-
cated that α ,β -MeATP did not affect c-fos
luciferase, providing additional evidence that
the pathway of activation was neither a
P2X1 or P2X3 receptor. A second antago-
nist, oxATP, which is irreversible and more
selective for P2X receptors (21), inhibited
nearly fully the actions of ATP on c-fos
luciferase in GH4C1 cells. Because oxATP
has been reported to have some degree of
selectivity for P2X7 receptors, we tested an
agonist, BzATP, which has selectivity for
P2X7 receptors (21–23). BzATP failed to
increase c-fos luciferase in GH4C1 cells, but
it did cause a concentration-dependent inhi-
bition of luciferase activity. BzATP was
nearly 10 times more potent at inhibiting c-
fos luciferase than ATP. BzATP induces
greater maximal ion conductance than ATP
in cells expressing P2X7 receptors; this may
be the basis for the greater efﬁcacy of BzATP
for cytotoxicity (21). The action of BzATP
was fully inhibited by oxATP. Taken
together, these analog selectivity experiments
with BzATP and oxATP are consistent with
the presence of P2X7 receptors on GH4C1
cells. The presence of P2X7 receptors on
GH4C1 cells was additionally supported by
the immunostaining of Western transfers of
GH4C1 cell membranes using an antibody
specific to the unique carboxy terminal
domain of the P2X7 receptor.
ATP-activated ion channel receptors
were originally identified in mast cells (24)
and later found in other myeloid-derived
cells, including macrophages and microglia
(25,26). These channels, designated P2Z,
were subsequently found to be of the P2X
class and renamed P2X7 (27). Although the
P2X7 receptor subtype is found largely in
cells of immune origin, it has also been iden-
tiﬁed in cell lines and primary cell cultures of
nonimmune origin (18,28,29). The role for
a P2X7 receptor in GH4C1 cells has not
been determined; however, it is well known
that this cell lineage (growth hormone-pro-
ducing cells) mediates local inflammatory
responses in the pituitary gland and may
modulate the hypothalamic pituitary axis
during systemic inﬂammatory reactions (30). 
The antagonists PPADS and oxATP,
which we used to characterize the P2X
receptor in GH4C1 cells, were also useful in
examining the action of pPfTx. The path-
way(s) leading to the biphasic effect on c-fos
luciferase of pPfTx in GH4C1 cells appears
to be mediated by the same receptor that
mediates the response to ATP. Both PPADS
and oxATP inhibited pPfTx induction of c-
fos luciferase. These results are consistent
with pPfTx acting as a P2X7 receptor ago-
nist. Although these results do not prove
that P2X7 is the initial cellular target for the
putative toxin, they do indicate that this
receptor is necessary in the signal transduc-
tion pathway. At this point it is not possible
to exclude effects of pPfTx on additional
receptors, including other P2X receptor sub-
types. This may be most readily determined
using expression systems for various cloned
receptors.
It remains to be determined whether the
P2X7 agonist activity isolated from P. pisci-
cida is responsible for the wildlife effects asso-
ciated with this organism. Macrophages and
mast cells express P2X7 receptors, which have
been suggested to have a role in inflamma-
tion. The entry of monocytes into peripherial
tissues precedes their differentiation into acti-
vated macrophages, a process that involves the
action of interferon-γ , which in turn leads to
expression of P2X7 receptors (31). In acti-
vated macrophages, P2X7 receptors mediate
chronic inﬂammatory responses normally dri-
ven by ATP. The responses include fusion of
macrophages into multinucleated giant cells
and several inﬂammatory responses that result
from production of interleukin 1-β , including
release of prostaglandins, production of
matrix, and chemoattraction of neutophils
(32–34). These responses are characteristic of
granulatomatous lesions found in ﬁsh that are
associated with toxic P. piscicida (9,35).
Because P. piscicida has the capacity to phago-
cytize blood cells and cause tissue injury (2), it
may initiate an acute inflammation that is
potentiated to a chronic response by pPfTx,
behaving as a potent ATP mimic at P2X7
receptors on activated macrophages.
Whether the P2X7 agonist activity iso-
lated from P. piscicida contributes to the
human neurocognitive effects associated with
this organism is less obvious. P2X7 receptors
in the central nervous system have been best
characterized in microglia (31,36). Microglia
are the central nervous system counterpart to
tissue macrophages and they normally pro-
vide a defensive inflammatory response to
infections and tissue damage (37). However,
inappropriate activation of microglia can
elicit neurotoxic effects that may include
release of excitotoxic amino acids and
cytolytic and inﬂammatory agents (37). One
approach used to study the effects of Pﬁesteria
on neurocognitive impairment is a rat model
using radial arm-maze testing (38).
Our results indicate that the cytotoxic
effect originally described for a putative P. pis-
cicida toxin is mediated by a P2X7 receptor.
Based on the current understanding of the role
of P2X7 receptors in disease and the observed
effects directly attributable to exposure to P.
piscicida toxins, P2X7 receptor-mediated
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Figure 11. oxATP and PPADS inhibition of ATP and
pPfTx induction of c-fos luciferase in GH4C1 cells
pretreated with 400 mM oxATP for 1 hr then
treated with increasing concentrations of ATP and
pPfTx. RLU, relative light units. See “Materials and
Methods” for details. The oxATP treatment did not
differ from the vehicle [Milli-Q-treated water
(Millipore, Bedford, MA), ﬁnal concentration 2.5%]
but did cause a significant (Tukey multiple com-
parison test, p < 0.05) difference in pPfTx induction
of c-fos luciferase. Each point represents the
mean ± SE of three wells for an experiment
repeated once with similar results.
Figure 10. PPADS inhibition of pPfTx induction of
c-fos luciferase in GH4C1 cells treated with ATP or
pPfTx. RLU, relative light units. See “Materials
and Methods” for details. The ATP and pPfTx
treatments differed (Tukey multiple comparison
test, p < 0.05) from the vehicle [Milli-Q-treated
water (Millipore, Bedford, MA), final concentra-
tion 2.5%] for the control group but not for the
PPADS group. Each point represents the mean ±
SE of three wells for an experiment repeated
once with similar results. 
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pPfTxchronic inﬂammation may provide a basis to
better understand the animal and human tox-
icity associated with this organism.
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